Literature DB >> 2948642

Intracoronary thrombolysis: organizational prerequisites, technique, and results.

W Rutsch, H Schmutzler.   

Abstract

Reestablishing myocardial perfusion during evolving myocardial infarction may limit the ultimate extent of infarction if viable myocardial tissue is present when recanalization of the occluded vessel is achieved. This will result in improved left ventricular function and decreased mortality. In addition to their therapeutic benefits, recanalization procedures have contributed greatly to our knowledge of acute myocardial infarction. It has been demonstrated that myocardial infarction most often occurs after thrombotic occlusion of a coronary artery. This has settled a controversy that has preoccupied cardiologists for decades. Selective intracoronary administration of fibrinolytic agents is followed by recanalization in approximately 80% of cases. Therapeutic failures are attributable to occlusion caused by other factors, to inactivation of streptokinase by high antibody concentrations, and to insufficient concentrations of streptokinase at the thrombus as a result of unfavorable flow conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948642     DOI: 10.1007/bf02577953

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  48 in total

1.  Consequences of reperfusion after coronary occlusion. Effects on hemodynamic and regional myocardial metabolic function.

Authors:  T W Lang; E Corday; H Gold; S Meerbaum; S Rubins; C Costantini; S Hirose; J Osher; V Rosen
Journal:  Am J Cardiol       Date:  1974-01       Impact factor: 2.778

2.  Percutaneous transluminal coronary recanalization: procedure, results, and acute complications.

Authors:  W Rutsch; M Schartl; D Mathey; K Kuck; W Merx; R Dörr; P Rentrop; H Blanke
Journal:  Am Heart J       Date:  1981-12       Impact factor: 4.749

3.  Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion.

Authors:  P S Puri; K G Varley; S W Kim; J Barwinsky; M Cohen; N S Dhalla
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

4.  A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction.

Authors:  R H Leiboff; R J Katz; A G Wasserman; G B Bren; H Schwartz; P J Varghese; A M Ross
Journal:  Am J Cardiol       Date:  1984-02-01       Impact factor: 2.778

5.  Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction.

Authors:  K P Rentrop; F Feit; H Blanke; P Stecy; R Schneider; M Rey; S Horowitz; M Goldman; K Karsch; H Meilman
Journal:  N Engl J Med       Date:  1984-12-06       Impact factor: 91.245

6.  Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction.

Authors:  S Goldberg; A J Greenspon; P L Urban; B Muza; B Berger; P Walinsky; P R Maroko
Journal:  Am Heart J       Date:  1983-01       Impact factor: 4.749

7.  Experimental coronary artery occlusion. I. Measurement of infarct size.

Authors:  W Schaper; H Frenzel; W Hort
Journal:  Basic Res Cardiol       Date:  1979 Jan-Feb       Impact factor: 17.165

8.  The international registry to support approval of intracoronary streptokinase thrombolysis in the treatment of myocardial infarction. Assessment of safety and efficacy.

Authors:  J Weinstein
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

9.  Treatment of myocardial infarction with intracoronary streptokinase: efficacy and safety data from 209 United States cases in the Hoechst-Roussel registry.

Authors:  J Weinstein
Journal:  Am Heart J       Date:  1982-10       Impact factor: 4.749

10.  Intracoronary thrombolysis in evolving myocardial infarction.

Authors:  W Ganz; N Buchbinder; H Marcus; A Mondkar; J Maddahi; Y Charuzi; L O'Connor; W Shell; M C Fishbein; R Kass; A Miyamoto; H J Swan
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

View more
  2 in total

Review 1.  Reactive oxygen metabolites and the human myocardium.

Authors:  C J Burrell; D R Blake
Journal:  Br Heart J       Date:  1989-01

Review 2.  Thrombolytic treatment and new calcium antagonists.

Authors:  J Feely; T Pringle; D Maclean
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.